Saudi Pharmaceutical Industries and Medical Appliances Corporation (2070.SR)
SAR 31.65
(-0.32%)
SAR 31.65
(-0.32%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -13.71 Million SAR | 98.24% |
| 2022 | -170.23 Million SAR | -743.5% |
| 2021 | 26.45 Million SAR | -78.8% |
| 2020 | 124.78 Million SAR | 125.94% |
| 2019 | -481.07 Million SAR | -567.84% |
| 2018 | 102.82 Million SAR | -47.9% |
| 2017 | 197.36 Million SAR | -47.61% |
| 2016 | 376.69 Million SAR | 5.5% |
| 2015 | 357.05 Million SAR | 12.69% |
| 2014 | 316.85 Million SAR | 18.75% |
| 2013 | 266.82 Million SAR | 14.7% |
| 2012 | 232.63 Million SAR | 10.03% |
| 2011 | 211.43 Million SAR | 19.78% |
| 2010 | 176.52 Million SAR | 14.03% |
| 2009 | 154.8 Million SAR | 20.69% |
| 2008 | 128.26 Million SAR | 5.26% |
| 2007 | 121.86 Million SAR | 22.91% |
| 2006 | 99.14 Million SAR | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 35.6 Million SAR | 182.81% |
| 2024 Q2 | 33.11 Million SAR | -7.01% |
| 2023 Q3 | -40.97 Million SAR | -283.79% |
| 2023 Q1 | 54.74 Million SAR | 152.52% |
| 2023 FY | -3 Million SAR | 98.24% |
| 2023 Q2 | 22.29 Million SAR | -59.28% |
| 2023 Q4 | -43 Million SAR | -4.95% |
| 2022 FY | -170.23 Million SAR | -743.5% |
| 2022 Q4 | -104.22 Million SAR | -127.37% |
| 2022 Q3 | -45.84 Million SAR | 11.65% |
| 2022 Q1 | 33.32 Million SAR | 187.34% |
| 2022 Q2 | -51.88 Million SAR | -255.69% |
| 2021 Q4 | -38.15 Million SAR | -615.83% |
| 2021 Q2 | 31.06 Million SAR | 18.82% |
| 2021 FY | 26.45 Million SAR | -78.8% |
| 2021 Q3 | 7.39 Million SAR | -76.19% |
| 2021 Q1 | 26.14 Million SAR | 298.11% |
| 2020 Q1 | 45.6 Million SAR | 116.92% |
| 2020 Q3 | 67.4 Million SAR | 169.86% |
| 2020 FY | 124.78 Million SAR | 125.94% |
| 2020 Q4 | -13.19 Million SAR | -119.58% |
| 2020 Q2 | 24.97 Million SAR | -45.22% |
| 2019 Q2 | -182.62 Million SAR | -1379.77% |
| 2019 FY | -481.07 Million SAR | -567.84% |
| 2019 Q3 | 28.11 Million SAR | 115.39% |
| 2019 Q4 | -269.54 Million SAR | -1058.79% |
| 2019 Q1 | -12.34 Million SAR | -190.54% |
| 2018 Q3 | -1.97 Million SAR | -104.24% |
| 2018 Q1 | 55.22 Million SAR | 32.59% |
| 2018 FY | 102.82 Million SAR | -47.9% |
| 2018 Q4 | 13.63 Million SAR | 790.65% |
| 2018 Q2 | 46.56 Million SAR | -15.69% |
| 2017 Q2 | 46.56 Million SAR | -54.0% |
| 2017 FY | 197.36 Million SAR | -47.61% |
| 2017 Q3 | 7.92 Million SAR | -82.99% |
| 2017 Q1 | 101.21 Million SAR | -52.2% |
| 2017 Q4 | 41.65 Million SAR | 425.83% |
| 2016 Q3 | 6.75 Million SAR | -82.95% |
| 2016 Q1 | 88.91 Million SAR | 1075.3% |
| 2016 FY | 376.69 Million SAR | 5.5% |
| 2016 Q2 | 39.61 Million SAR | -55.45% |
| 2016 Q4 | 211.76 Million SAR | 3034.65% |
| 2015 Q2 | 237.62 Million SAR | 139.09% |
| 2015 Q1 | 99.38 Million SAR | 8.88% |
| 2015 Q3 | 29.15 Million SAR | -87.73% |
| 2015 FY | 357.05 Million SAR | 12.69% |
| 2015 Q4 | -9.11 Million SAR | -131.27% |
| 2014 Q4 | 91.28 Million SAR | 148.81% |
| 2014 Q3 | 36.68 Million SAR | -62.45% |
| 2014 Q2 | 97.71 Million SAR | 7.18% |
| 2014 Q1 | 91.16 Million SAR | 59.92% |
| 2014 FY | 316.85 Million SAR | 18.75% |
| 2013 Q1 | 63.14 Million SAR | 17.61% |
| 2013 Q3 | 34.19 Million SAR | -69.93% |
| 2013 Q4 | 57 Million SAR | 66.72% |
| 2013 FY | 266.82 Million SAR | 14.7% |
| 2013 Q2 | 113.7 Million SAR | 80.07% |
| 2012 Q4 | 53.69 Million SAR | 65.99% |
| 2012 FY | 232.63 Million SAR | 10.03% |
| 2012 Q3 | 32.34 Million SAR | 0.0% |
| 2011 FY | 211.43 Million SAR | 19.78% |
| 2010 FY | 176.52 Million SAR | 14.03% |
| 2009 FY | 154.8 Million SAR | 20.69% |
| 2008 FY | 128.26 Million SAR | 5.26% |
| 2007 FY | 121.86 Million SAR | 22.91% |
| 2006 FY | 99.14 Million SAR | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Jamjoom Pharmaceuticals Factory Company | 292.4 Million SAR | 104.689% |